BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 36689167)

  • 1. Cancer Stem Cells and Their Therapeutic Usage.
    Osum M; Kalkan R
    Adv Exp Med Biol; 2023; 1436():69-85. PubMed ID: 36689167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
    Paul R; Dorsey JF; Fan Y
    Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
    Marcucci F; Ghezzi P; Rumio C
    Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
    CeliĆ -Terrassa T; Jolly MK
    Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31570380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The strategies to cure cancer patients by eradicating cancer stem-like cells.
    Mai Y; Su J; Yang C; Xia C; Fu L
    Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications.
    Li D; Peng X; He G; Liu J; Li X; Lin W; Fang J; Li X; Yang S; Yang L; Li H
    Cell Death Dis; 2023 Jul; 14(7):409. PubMed ID: 37422448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.